Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin for IVF success in infertile women with polycystic ovary syndrome
IRCT20231126060191N1Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of atorvastatin in polycystic ovary syndrome (PCOS) and female infertility, sponsored by Kashan University of Medical Sciences. Primary endpoint: The success rate of IVF. Started May 2024; status: completed.
02
Drugs
atorvastatin
03
Conditions
polycystic ovary syndrome (PCOS)female infertility
Beyond the preview
Go deeper on IRCT20231126060191N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231126060191N1.